Integrating digital technologies to clinical research & trial operations.
JNPMEDI Distributes FDA’s ‘Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations Questions and Answers’ Guidance in Korean.
JNPMEDI acquires a platinum membership in the "Clinical Data Interchange Standard Consortium (CDISC)."
MOU with ProSciento to cooperate toward the mutual goal of providing the healthcare industry.
JNPMEDI Signs Strategic Business Agreement with Korea University Medical Center for Digitalization of Clinical Trials
JNPMEDI succeeded in attracting 14 billion won worth of Series A investment.
Thank you for attending JNPMEDI Connect 2022